Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sahel86
    Junior Member
    • Aug 2012
    • 2

    DEXSeq, estimatelog2FoldChanges error

    Hi there,
    I ran to a problem with estimatelog2FoldChanges command in DEXSeq.
    > Mydata <- estimatelog2FoldChanges(Mydata)
    Calculating fold changes. (Progress report: one dot per 100 genes)
    Error in do.call(`[[<-`, c(quote(coefIndices), as.list(lvlTbl[i, ]), coefNames[i])) :
    [[ ]] subscript out of bounds
    I traced the error and find out it is originally made by this line :
    > coefIndices <- do.call(`[[<-`, c(quote(coefIndices), as.list(lvlTbl[i, ]), coefNames[i]))
    which is a line of DEXSeq:::arrangeCoefs function.

    Any ideas what could possibly went wrong here and caused this error?????

    Thanks alot,
    Sahel
    Last edited by sahel86; 08-30-2012, 04:29 PM.
  • sahel86
    Junior Member
    • Aug 2012
    • 2

    #2
    The issue has been resolved.

    Comment

    • RedLightPanic
      Junior Member
      • Jan 2013
      • 9

      #3
      Hi sahel86,

      I'm having the same error message when trying to call estimatelog2FoldChanges on my ExonCountSet object.

      Could you please explain me how did you solve the issue?

      Thanks in advance.

      Comment

      • areyes
        Senior Member
        • Aug 2010
        • 165

        #4
        HI RedLightPanic,

        Could you include the output of your sessionInfo()?

        Alejandro

        Comment

        • RedLightPanic
          Junior Member
          • Jan 2013
          • 9

          #5
          Hi Alejandro,

          Here is the error message:

          > ECS_ecs <- estimatelog2FoldChanges(ECS_ecs)
          Error in do.call(`[[<-`, c(quote(coefIndices), as.list(lvlTbl[i, ]), coefNames[i])) :
          [[ ]] subscript out of bounds


          And here the output of my sessionInfo()

          > sessionInfo()
          R version 2.15.2 (2012-10-26)
          Platform: x86_64-unknown-linux-gnu (64-bit)

          locale:
          [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
          [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
          [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
          [7] LC_PAPER=C LC_NAME=C
          [9] LC_ADDRESS=C LC_TELEPHONE=C
          [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C

          attached base packages:
          [1] parallel stats graphics grDevices utils datasets methods
          [8] base

          other attached packages:
          [1] DEXSeq_1.4.0 Biobase_2.18.0 BiocGenerics_0.4.0

          loaded via a namespace (and not attached):
          [1] biomaRt_2.14.0 hwriter_1.3 plyr_1.7.1 RCurl_1.95-3 statmod_1.4.16
          [6] stringr_0.6.1 XML_3.95-0.1


          Thanks in advance for your help!

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            Yesterday, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 11:10 AM
          0 responses
          8 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          30 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          39 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Working...